GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Piramal Pharma Ltd
Piramal Pharma Ltd — Management Change Disclosed
MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 28 Apr 2026, 09:23 PM IST  ·  BSE ID: 9dd84320-5a42-47a2-add4-e8a183a3d6fc
View Original BSE Filing (PDF)
💡
In Simple Terms
Piramal Pharma announced a change in management, but the details were not readable in the filing.
🤖 AI Summary
  • Management change disclosed by Piramal Pharma Ltd on 28 April 2026
  • Filing references attached details; PDF document unavailable for review
  • Specific change details—appointment, resignation, or reclassification—unconfirmed without attachment
  • Shareholders must access full attachment via company or BSE portal for complete information
🏢 How This Affects the Company
⚙️
Operational Impact
Management change affects operational continuity and governance structure; specifics require access to full filing attachment.
👥 What This Means For Shareholders
✅
Action Required
Shareholders should request full filing attachment from company investor relations or BSE portal to confirm management change details.
👤
Who Is Affected
All shareholders are affected if change impacts board composition, key management personnel, or governance structure; specific impact cannot be quantified without attachment.
🔍
Management Signal
Filing filed under Regulation 30 LODR indicates management change is material; specific intent cannot be assessed without document access.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Company investor relations announcement — confirm management change details and effective date
BSE filing archive — obtain full PDF attachment for complete regulatory disclosure
Next quarterly results filing — monitor for management commentary on transition and continuity
MEDIUM RISK Management change is flagged as material, but lack of document access prevents risk assessment. Full details required to evaluate operational continuity.
💡 Investor Takeaway
Piramal Pharma disclosed a management change on 28 April 2026, but the filing attachment was inaccessible. Shareholders cannot determine the scope, affected positions, or effective date without obtaining the complete document from company or BSE records.
⚖️ Strengths & Concerns

⚠️ Concerns

  • PDF attachment unavailable — prevents verification of change scope and management continuity impact
  • No specific names, roles, or effective dates provided — creates information gap for shareholders
📅 Company Track Record
No previous filings found for this company in available records.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.